Employers who use technological advancement to reshape workers’ jobs can help improve patient care while improving the work experience of frontline health care workers, Associate Professor Adam Seth Litwin argues in a peer-reviewed commentary.
Globally, by the end of this century low-income cattle farmers in poor countries may face financial loss between $15 to $40 billion annually, due to looming climate change.
Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.
Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Cole, M.D. ’94, is the assistant vice provost for information services and chief information officer at Weill Cornell Medicine. He will begin his new role Jan. 1, 2023.
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
Abnormalities in a type of brain cell called astrocytes may play a pivotal role in causing some behavioral symptoms of autism spectrum disorders, according to a preclinical study by Weill Cornell Medicine investigators.
A growing percentage of U.S. adults, even those who trust science, said harassing or threatening public health officials over COVID-19 business closures was justified, according to a new study of public opinion surveys conducted during two phases of the pandemic.